| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 48.892 | 45.094 | 46.417 | 9.318 | 12.937 | 17.586 | 43.999 | 51.484 | 48.959 |
| Total Income - EUR | - | 48.892 | 45.094 | 46.417 | 9.318 | 12.937 | 17.586 | 43.999 | 51.484 | 48.959 |
| Total Expenses - EUR | - | 601 | 610 | 628 | 851 | 3.313 | 7.045 | 5.314 | 12.602 | 12.400 |
| Gross Profit/Loss - EUR | - | 48.291 | 44.484 | 45.789 | 8.467 | 9.624 | 10.541 | 38.685 | 38.881 | 36.558 |
| Net Profit/Loss - EUR | - | 46.824 | 43.132 | 44.396 | 8.187 | 9.476 | 10.285 | 37.849 | 38.377 | 36.077 |
| Employees | - | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Proasimed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 0 | 0 | 0 | 0 | 0 | 5.780 | 3.967 | 2.130 | 303 |
| Current Assets | - | 48.042 | 44.654 | 45.381 | 8.238 | 11.766 | 7.377 | 35.828 | 37.842 | 39.372 |
| Inventories | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | 47.964 | 44.260 | 42.553 | 7.474 | 10.871 | 6.827 | 34.506 | 35.767 | 37.791 |
| Cash | - | 0 | 394 | 2.827 | 764 | 894 | 550 | 1.322 | 2.074 | 1.581 |
| Shareholders Funds | - | 46.869 | 43.175 | 44.448 | 8.238 | 9.535 | 10.512 | 37.908 | 38.435 | 36.136 |
| Social Capital | - | 45 | 44 | 43 | 42 | 52 | 51 | 51 | 51 | 50 |
| Debts | - | 1.174 | 1.479 | 933 | 0 | 2.230 | 2.645 | 1.887 | 1.536 | 3.539 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8211 - 8211" | |||||||||
| CAEN Financial Year |
8211
|
|||||||||
Comments - Proasimed Srl